ArticleFundamental research2025

The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide.

Shanqiang Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.